E.U.’s Midterm Budget Review Provides Opportunity To Exhibit Leadership In Global Health Innovation

Devex: Opinion: Global health innovation is a prescription for European leadership
Cécile Vernant, head of E.U. advocacy for Deutsche Stiftung Weltbevölkerung (DSW)

“…In order to achieve [the Sustainable Development Goals (SDGs)], governments throughout the world need to urgently scale up their investment in global health innovation — developing new vaccines, drugs, and diagnostics that will be key to a 2030 that is free from diseases of poverty. … In 2017, the E.U. is undertaking a midterm review of its seven-year budget, identifying priorities for the next three years for the overall budget and the E.U.’s research program, Horizon2020. The E.U. will also launch discussions for the next multiyear budget cycle, to launch in 2020. These parallel processes provide a critical opportunity for the E.U. to assess what its funding for global health innovation has achieved, where it can be improved, and how much additional investment is needed. Here are three ways that Europe can grasp this opportunity. 1. Meet[ing] its funding targets. … 2. Improving synergies. … 3. Making investment more effective…” (11/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.